Collegium Pharmaceutical Inc
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts. Show More...
-
Website https://www.collegiumpharma.com
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 25.20 EUR
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -0.92 -2.84 -1.48 -3.88 -2.47 -1.19 -0.68 -0.38 Dividends USD Payout Ratio % * Shares Mil 7.0 7.0 14.0 24.0 30.0 33.0 33.0 34.0 Book Value Per Share * EUR 2.39 2.46 1.86 2.24 3.71 Free Cash Flow Per Share * EUR -2.65 -2.27 2.43 1.27 Return on Assets % -76.19 -300.44 -38.95 -72.52 -50.32 -18.34 -7.61 -2.71 Financial Leverage (Average) 1.15 1.2 1.3 3.18 3.5 4.5 Return on Equity % -54.98 -85.62 -62.65 -39.99 -25.39 -11.06 Return on Invested Capital % -42.27 -81.48 -61.58 -18.93 -22.39 -3.18 Interest Coverage -212.12 -70.1 -61.08 -0.94 -24.0 -1.29 Current Ratio 3.16 0.43 11.49 6.2 4.24 1.26 1.27 0.92 Quick Ratio 2.88 0.16 11.35 6.07 4.09 1.19 1.2 0.82 Debt/Equity 0.05 0.010 0.11 0.2 1.77